Skip to main content

Table 3 DFS of colorectal cancer after incorporation of serum basophil count level into conventional AJCC TNM staging system

From: Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer

AJCC TNM staging system

After incorporation of C-stage into AJCC stage

Stage

No. of patients

Disease-free survival

Stage

No. of patients

Disease-free survival

HR (95% CI)

P value

HR (95% CI)

P value

I

141

1

I B−

49

1

I B+

92

0.270 (0.149–0.488)

< 0.001

IIA

123

1.340 (0.895–2.005)

0.155

IIA B−

50

1.174 (0.701–1.968)

0.542

IIA B+

73

0.407 (0.228–0.727)

0.002

IIB

128

1.668 (1.138–2.447)

0.009

IIB B−

46

1.412 (0.850–2.345)

0.183

IIB B+

82

0.548 (0.327–0.918)

0.022

IIC

8

1.501 (0.591–3.814)

0.393

IIC B−

6

1.238 (0.430–3.569)

0.692

IIC B+

2

0.445 (0.060–3.318)

0.430

IIIA

44

1.317 (0.762–2.275)

0.324

IIIA B−

16

0.891 (0.414–1.919)

0.769

IIIA B+

28

0.542 (0.260–1.133)

0.103

IIIB

327

2.617 (1.852–3.697)

< 0.001

IIIB B−

148

1.932 (1.249–2.988)

0.003

IIIB B+

179

1.002 (0.643–1.559)

0.995

IIIC

258

3.478 (2.424–4.990)

< 0.001

IIIC B−

127

2.679 (1.714–4.187)

< 0.001

IIIC B+

131

1.275 (0.809–2.008)

0.295